AMR – From Commitments to Measurable Action
The Global Business for Health Partnership will bring together senior representatives from G20 governments, global health leads and industry to discuss the importance of effectively addressing antimicrobial resistance (AMR).
COVID-19 has shown the world how devastating a pandemic can be, particularly in countries where pandemic preparedness was limited. The looming crisis posed by AMR is huge. The UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance has warned that drug-resistant diseases could cause 10 million deaths each year by 2050 and damage to the economy as catastrophic as the 2008-2009 global financial crisis, if no action is taken.
By 2030, antimicrobial resistance could force up to 24 million people into extreme poverty. To date, political rhetoric has been strong but meaningful activity has been lacking. The recent establishment of the One Health Global Leaders Group on AMR and the release of its action plan presents a good opportunity for further discussions and charting of next steps in driving concrete action by governments, but also other stakeholders.